Loading insider details...
Latest Form 4 (May 15, 2026): Disposition to Issuer of 640 LYRA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 15, 2026 | Lyra Therapeutics, Inc. (LYRA) | Disposition to Issuer | 640 | n/a |
| May 16, 2025 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 32,000 | n/a |
| Jun 14, 2024 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 30,000 | n/a |
| Jul 6, 2023 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 20,000 | n/a |
| Feb 27, 2023 | Homology Medicines, Inc. (FIXX) | Grant/Award | 213,000 | n/a |
| Jan 11, 2023 | Homology Medicines, Inc. (FIXX) | Sale | 3,729 | $5.2K |
| Jan 4, 2023 | Homology Medicines, Inc. (FIXX) | Exercise/Conversion | 6,600 | n/a |
| Jun 21, 2022 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 7,250 | n/a |
| Feb 28, 2022 | Homology Medicines, Inc. (FIXX) | Grant/Award | 126,000 | n/a |
| Jan 12, 2022 | Homology Medicines, Inc. (FIXX) | Exercise/Conversion | 6,600 | n/a |